CNWDX
Price
$17.39
Change
-$0.07 (-0.40%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

CNWDX vs RNWFX

Header iconCNWDX vs RNWFX Comparison
Open Charts CNWDX vs RNWFXBanner chart's image
Calamos Evolving World Growth C
Price$17.39
Change-$0.07 (-0.40%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
CNWDX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNWDX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNWDX is a Hold and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. CNWDX (379M). RNWFX pays higher dividends than CNWDX: RNWFX (1.51) vs CNWDX (0.00). CNWDX was incepted earlier than RNWFX: CNWDX (16 years) vs RNWFX (23 years). CNWDX is a more actively managed with annual turnover of: 137.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than CNWDX: RNWFX (250) vs CNWDX (2500). CNWDX annual gain was more profitable for investors over the last year : 15.24 vs. RNWFX (5.86). CNWDX return over 5 years is better than : 24.84 vs. RNWFX (14.39).
CNWDXRNWFXCNWDX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD13.6604.549300%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets379M62.2B1%
Annual Yield % from dividends0.001.51-
Returns for 1 year15.245.86260%
Returns for 3 years-8.86-5.10174%
Returns for 5 years24.8414.39173%
Returns for 10 years40.0242.6794%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics